Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Accumulated amortization of deferred leasing costs $ 35,270 $ 31,768
Common Shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common Shares of beneficial interest, shares authorized (in shares) 150,000,000 150,000,000
Common Shares of beneficial interest, shares issued (in shares) 112,423,893 112,327,533
Common Shares of beneficial interest, shares outstanding (in shares) 112,423,893 112,327,533
Investing Receivables    
Investing receivable allowance for credit loss $ 2,794 $ 1,599